z-logo
open-access-imgOpen Access
Promising FDA-approved drugs with efflux pump inhibitory activities against clinical isolates of Staphylococcus aureus
Author(s) -
Safaa Abdel-Aal Mohamed Abdel-Karim,
Amira M. El-Ganiny,
Mona A. El-Sayed,
Hisham A. Abbas
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0272417
Subject(s) - staphylococcus aureus , efflux , pharmacology , methicillin resistant staphylococcus aureus , microbiology and biotechnology , medicine , chemistry , biology , bacteria , biochemistry , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom